FRR Intuition in One Sentence
Final lipid concentration = lipid stock / (FRR + 1). That is the whole ballgame.
A 10 mg/mL lipid stock at FRR 3:1 gives a 2.5 mg/mL final formulation — the stock is diluted 4-fold (FRR + 1) by the aqueous phase. At FRR 5:1 the same stock gives 1.67 mg/mL, and at FRR 1:1 it gives 5 mg/mL.
This is why vendors publish FRRs of exactly 3:1 for most mRNA-LNP protocols: it is the default that translational labs converged on after years of optimization, and it pairs well with stock solutions in the 8–12 mg/mL range.
Residence Time and Particle Size
LNP self-assembly is a fast, kinetically controlled process. When the organic and aqueous phases mix, the ethanol concentration drops, and lipids precipitate into particles on a millisecond timescale.
If the mixer residence time is too short (< 5 ms), particles may not finish assembling before leaving the mixer. If too long (> 100 ms), particles can aggregate. The sweet spot for most mRNA-LNP systems is 10–50 ms, achieved at TFR 8–15 mL/min in standard herringbone chips.
Scaling up TFR to reduce residence time is the most common optimization knob in LNP production.
Two Syringes vs Dual-Syringe vs Pressure Controllers
Two independent syringe pumps give you full control but require careful flow-rate calibration between pumps, and any pulsation in one pump shows up as polydispersity.
A single dual-syringe pump (e.g. Chemyx Fusion 4000x) eliminates pump-to-pump drift — one motor drives both syringes through a gearbox at the correct ratio. This is the preferred setup for FRR 3:1 production because the motor physically enforces the ratio.
Pressure controllers (Fluigent, Elveflow) give extremely smooth flow but require you to close the loop on flow rate with inline sensors. Use them for very low TFR or for highly sensitive formulations where any pulsation would hurt monodispersity.
